» Articles » PMID: 35128247

Synthesis and Antiproliferative Activity of Triphenylphosphonium Derivatives of Natural Allylpolyalkoxybenzenes

Abstract

Derivatives of natural allylpolyalkoxybenzenes conjugated to triphenylphosphonium (TPP) cations by aliphatic linkers of three, six, seven, and eight atoms were synthesized to examine the role of the polyalkoxybenzene pharmacophore, TPP fragment, and linker length in antiproliferative activities. The key synthetic procedures included (i) hydroboration-oxidation of apiol, dillapiol, myristicin, and allyltetramethoxybenzene; (ii) acylation of polyalkoxybenzyl alcohols or amines; and (iii) condensation of polyalkoxybenzaldehydes followed by hydrogenation and cyclopropyl-homoallyl rearrangement. The targeted TPP conjugates as well as the starting allylbenzenes, the corresponding alkylpolyalkoxybenzenes, and the respective alkyl-TPP salts were evaluated for cytotoxicity in a panel of human cancer cell lines using MTT and Click-iT-EdU assays and in a sea urchin embryo model. The linker of three carbon atoms was identified as favorable for selective cancer cell growth inhibition. Although the propyl-TPP salt was cytotoxic at low micromolar concentrations, the introduction of a polyalkoxybenzene moiety significantly potentiated inhibition of both cell growth and DNA synthesis in several human cancer cell lines, HST-116 colon cancer, A375 melanoma, PC-3 prostate cancer, and T-47D breast carcinoma cells, while it failed to produce any developmental abnormalities in the sea urchin embryos.

Citing Articles

Triphenylphosphine Derivatives of Allylbenzenes Express Antitumor and Adjuvant Activity When Solubilized with Cyclodextrin-Based Formulations.

Zlotnikov I, Krylov S, Semenova M, Semenov V, Kudryashova E Pharmaceuticals (Basel). 2023; 16(12).

PMID: 38139778 PMC: 10747112. DOI: 10.3390/ph16121651.


Covalent Conjugates of Allylbenzenes and Terpenoids as Antibiotics Enhancers with the Function of Prolonged Action.

Zlotnikov I, Davydova M, Danilov M, Krylov S, Belogurova N, Kudryashova E Pharmaceuticals (Basel). 2023; 16(8).

PMID: 37631017 PMC: 10459265. DOI: 10.3390/ph16081102.

References
1.
Zielonka J, Joseph J, Sikora A, Hardy M, Ouari O, Vasquez-Vivar J . Mitochondria-Targeted Triphenylphosphonium-Based Compounds: Syntheses, Mechanisms of Action, and Therapeutic and Diagnostic Applications. Chem Rev. 2017; 117(15):10043-10120. PMC: 5611849. DOI: 10.1021/acs.chemrev.7b00042. View

2.
Asin-Cayuela J, Manas A, James A, Smith R, Murphy M . Fine-tuning the hydrophobicity of a mitochondria-targeted antioxidant. FEBS Lett. 2004; 571(1-3):9-16. DOI: 10.1016/j.febslet.2004.06.045. View

3.
Ross M, Prime T, Abakumova I, James A, Porteous C, Smith R . Rapid and extensive uptake and activation of hydrophobic triphenylphosphonium cations within cells. Biochem J. 2008; 411(3):633-45. DOI: 10.1042/BJ20080063. View

4.
Shi L, Chao C, Shen D, Chan H, Chen C, Liao Y . Biologically active constituents from the fruiting body of Taiwanofungus camphoratus. Bioorg Med Chem. 2010; 19(1):677-83. PMC: 3014437. DOI: 10.1016/j.bmc.2010.10.032. View

5.
Neuhaus-Carlisle K, Vierling W, Wagner H . Screening of plant extracts and plant constituents for calcium-channel blocking activity. Phytomedicine. 2012; 4(1):67-71. DOI: 10.1016/S0944-7113(97)80030-X. View